Additionally, TGF‐β1 expression is shown to be up‐regulated in HCC tissues with reduced SMARCB1 expression, indicating that SMARCB1 may participate in HCC suppression, and it may serve as an important prognostic biomarker and promising therapeutic target for HCC. Here, TGFB1 is linked to hepatocellular carcinoma.